94 related articles for article (PubMed ID: 7157083)
21. Chemosensitivity testing for human brain tumors.
Rosenblum ML
Prog Clin Biol Res; 1980; 48():259-76. PubMed ID: 7208520
[TBL] [Abstract][Full Text] [Related]
22. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
23. Use of an image analysis system to count colonies in stem cell assays of human tumors.
Kressner BE; Morton RR; Martens AE; Salmon SE; Von Hoff DD; Soehnlen B
Prog Clin Biol Res; 1980; 48():179-93. PubMed ID: 7193869
[No Abstract] [Full Text] [Related]
24. Diagnostic value of clot examination for malignant cells in serous effusions.
Jalal R; Aftab K; Hasan SH; Pervez S
Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
[TBL] [Abstract][Full Text] [Related]
25. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
[TBL] [Abstract][Full Text] [Related]
26. [Potentials and prospects of human tumor cloning methods].
Potapov SL; Korman DB
Med Radiol (Mosk); 1981 Jul; 26(7):59-64. PubMed ID: 7026956
[No Abstract] [Full Text] [Related]
27. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
28. Self-renewal and solid tumor stem cells.
Al-Hajj M; Clarke MF
Oncogene; 2004 Sep; 23(43):7274-82. PubMed ID: 15378087
[TBL] [Abstract][Full Text] [Related]
29. Standard laboratory procedures for in vitro assay of human tumor stem cells.
Soehnlen B; Young L; Liu R
Prog Clin Biol Res; 1980; 48():331-8. PubMed ID: 7208523
[No Abstract] [Full Text] [Related]
30. Potential and problems with growth of breast cancer in a human tumor cloning system.
Von Hoff DD; Sandbach J; Osborne CK; Metelmann C; Clark GM; O'Brien M
Breast Cancer Res Treat; 1981; 1(2):141-8. PubMed ID: 7348571
[TBL] [Abstract][Full Text] [Related]
31. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
32. Soft agar clonogenic assay for predicting chemosensitivity of human tumor cells from malignant effusions.
Ballet F; Petit J; Poupon R; Darnis F
Biomedicine; 1981 Nov; 35(6):177-8. PubMed ID: 7337802
[TBL] [Abstract][Full Text] [Related]
33. [Clonogenic capacity of proliferating and resting populations of NKLy/LL tumor cells].
Timcheva KV; Pelevina II
Vopr Onkol; 1981; 27(2):55-60. PubMed ID: 7210596
[TBL] [Abstract][Full Text] [Related]
34. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic variance among cells isolated from spontaneous mouse mammary tumors in primary suspension culture.
Soule HD; Maloney T; McGrath CM
Cancer Res; 1981 Mar; 41(3):1154-64. PubMed ID: 7459857
[TBL] [Abstract][Full Text] [Related]
36. Assessment of methods for primary tissue culture of human breast epithelia.
Croce MV; Colussi AG; Segal-Eiras A
J Exp Clin Cancer Res; 1998 Mar; 17(1):19-26. PubMed ID: 9646229
[TBL] [Abstract][Full Text] [Related]
37. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
[TBL] [Abstract][Full Text] [Related]
38. Initial experience with the human tumor stem cell assay system: potential and problems.
Von Hoff DD; Harris GJ; Johnson G; Glaubiger D
Prog Clin Biol Res; 1980; 48():113-24. PubMed ID: 7208514
[No Abstract] [Full Text] [Related]
39. [Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].
Denoux Y; Blanc-Vincent MP; Simony-Lafontaine Jl; Verriele-Beurrier V; Briffod M; Voigt JJ
Bull Cancer; 2002 Apr; 89(4):401-9. PubMed ID: 12016040
[TBL] [Abstract][Full Text] [Related]
40. The ChemoFx assay: an ex vivo cell culture assay for predicting anticancer drug responses.
Ochs RL; Burholt D; Kornblith P
Methods Mol Med; 2005; 110():155-72. PubMed ID: 15901934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
